Contraceptive prevalence, any modern method in Mauritania
Mauritania: Contraceptive prevalence, any modern method was 12.8% in 2021. ◆ Volatile
Contraceptive prevalence, any modern method in Mauritania, 1981–2021
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
Mauritania recorded 12.8% for contraceptive prevalence, any modern method in 2021.
That represents a change of up 28.0% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Mauritania peaked at 15.6% in 2015 and was at its lowest, 0.3%, in 1981.
Mauritania ranks 109th of 113 countries on this measure, in the bottom quarter.
Contraceptive prevalence, any modern method in Mauritania, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1981 | 0.3% | — |
| 1991 | 1.3% | +333.3% |
| 2001 | 5.1% | +292.3% |
| 2007 | 8.0% | +56.9% |
| 2011 | 10.0% | +25.0% |
| 2015 | 15.6% | +56.0% |
| 2021 | 12.8% | -17.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.3% | 0.3% | 0.3% | 1 |
| 1990s | 1.3% | 1.3% | 1.3% | 1 |
| 2000s | 6.5% | 5.1% | 8.0% | 2 |
| 2010s | 12.8% | 10.0% | 15.6% | 2 |
| 2020s | 12.8% | 12.8% | 12.8% | 1 |
Countries ranked near Mauritania
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Mauritania?
- Contraceptive prevalence, any modern method in Mauritania was 12.8% in 2021, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Mauritania?
- The highest recorded value was 15.6% in 2015.
- What is the lowest contraceptive prevalence, any modern method recorded in Mauritania?
- The lowest recorded value was 0.3% in 1981.
- How does Mauritania rank for contraceptive prevalence, any modern method?
- Mauritania ranks 109th out of 113 countries with data for 2021.
- Is contraceptive prevalence, any modern method rising or falling in Mauritania?
- Over the last ten years it is up 28.0%. The long-run trend across the full record is volatile.
- Where does this Mauritania data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.